Intriguingly, the inhibition of myostatin induced by gene manipulation or neutralizing antibody ameliorates sarcopenic obesity via increased skeletal muscle mass and improved glucose homeostasis. The gene discussed is MSTN; the disease is obesity due to melanocortin 4 receptor deficiency.